Endotrophin, a Multifaceted Player in Metabolic Dysregulation and Cancer Progression, Is a Predictive Biomarker for the Response to PPARγ Agonist Treatment

Diabetologia - Germany
doi 10.1007/s00125-016-4130-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-34a Is an Intracellular and Exosomal Predictive Biomarker for Response to Docetaxel With Clinical Relevance to Prostate Cancer Progression

Prostate
OncologyUrology
2014English

CD44: A Multifaceted Molecule in Cancer Progression

Journal of Cancer Prevention & Current Research
2017English

Metastasis-Associated Protein Is a Predictive Biomarker for Metastasis and Recurrence in Gastric Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Pretreatment Serum Cea as a Predictive Biomarker for the Response to Neoadjuvant Chemoradiotherapy: A Meta-Analysis in Rectal Cancer

Journal of Carcinogenesis & Mutagenesis
2015English

Tetrahydrocannabinolic Acid Is a Potent PPARγ Agonist With Neuroprotective Activity.

British Journal of Pharmacology
Pharmacology
2017English

Linking Obesogenic Dysregulation to Prostate Cancer Progression

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)

Journal of Pharmacogenomics & Pharmacoproteomics
2017English

The 26S Proteasome Is a Multifaceted Target for Anti-Cancer Therapies

Oncotarget
Oncology
2015English

Bone Marrow Micro-Environment Is a Crucial Player for Myelomagenesis and Disease Progression

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy